Skip to main content

CORRECTION article

Front. Genet., 27 July 2020
Sec. Genetics of Common and Rare Diseases
Volume 11 - 2020 | https://doi.org/10.3389/fgene.2020.00728

Corrigendum: Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells

This article is a correction to:

  1. Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells

    1. Read original article
\nNunzia MolloNunzia Mollo1Maria Nitti,Maria Nitti1,2Lucrezia ZerilloLucrezia Zerillo1Deriggio FaicchiaDeriggio Faicchia3Teresa MicilloTeresa Micillo4Rossella AccarinoRossella Accarino1Agnese SecondoAgnese Secondo5Tiziana PetrozzielloTiziana Petrozziello5Gaetano CalìGaetano Calì3Rita CicatielloRita Cicatiello1Ferdinando BonfiglioFerdinando Bonfiglio6Viviana SarnataroViviana Sarnataro1Rita GenesioRita Genesio1Antonella Izzo Antonella Izzo1*Paolo PintonPaolo Pinton2Giuseppe Matarese,Giuseppe Matarese1,3Simona PaladinoSimona Paladino1Anna ContiAnna Conti1Lucio Nitsch,Lucio Nitsch1,3
  • 1Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
  • 2Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy
  • 3Institute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy
  • 4Department of Biology, University of Naples Federico II, Naples, Italy
  • 5Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy
  • 6Department of Biomedicine, University of Basel, Basel, Switzerland

A Corrigendum on
Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells

by Mollo, N., Nitti, M., Zerillo, L., Faicchia, D., Micillo, T., Accarino, R, et al. (2019). Front. Genet. 10:606. doi: 10.3389/fgene.2019.00606

In the original article, there was an error in the Funding statement. The correction has been made to the Funding section by removing a funder “Lejeune Project #1698”:

LN was supported by grants POR Campania FSE 2007–2013 Project CREME from Campania Region, POR Campania FSE 2014–2020 from Campania Region. GM was supported by grants from European Research Council Grant “menTORingTregs” n. 310496, Fondazione Italiana Sclerosi Multipla (FISM) n. 2016/R/18 and Telethon n. GGP17086.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: Down syndrome/therapy, pioglitazone, energy metabolism, oxidative stress, mitochondrial dysfunction, mitochondrial dynamics

Citation: Mollo N, Nitti M, Zerillo L, Faicchia D, Micillo T, Accarino R, Secondo A, Petrozziello T, Calì G, Cicatiello R, Bonfiglio F, Sarnataro V, Genesio R, Izzo A, Pinton P, Matarese G, Paladino S, Conti A and Nitsch L (2020) Corrigendum: Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells. Front. Genet. 11:728. doi: 10.3389/fgene.2020.00728

Received: 12 June 2020; Accepted: 15 June 2020;
Published: 27 July 2020.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Mollo, Nitti, Zerillo, Faicchia, Micillo, Accarino, Secondo, Petrozziello, Calì, Cicatiello, Bonfiglio, Sarnataro, Genesio, Izzo, Pinton, Matarese, Paladino, Conti and Nitsch. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Antonella Izzo, YW50b25lbGxhLml6em8mI3gwMDA0MDt1bmluYS5pdA==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.